Royalty Report: Medical, Device, Diagnostic – Collection: 4807


Curated Royalty Rate Report
Created On: 2020-07-15, Record Count: 6


This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Created On: 2020-07-15
Record Count: 6

Primary Industries

  • Medical
  • Device
  • Diagnostic
  • Surgical
  • cardiac
  • Test/Monitoring
  • Ultrasound
  • Equipment
  • Needles
  • Catheter

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 4807

License Grant
The Company hereby grants within the Field of Use the exclusive rights to several ultrasound technologies for use in the field of electrophysiology.
License Property
Echomark (5,076,278)  means EchoCath's proprietary catheter positioning system which is covered by the Patents.

EchoEye (5,373,845) means proprietary technology for allowing clinicians to view tissues and organs in three-dimensional real-time and provide forward looking intravascular images and guidance for ultrasound guided procedures, and covered by the Patents.

ColorMark (5,329,927) means proprietary needle and stylete positioning system which is covered by the Patents.

Field of Use
Field of Use shall include the application of the EchoMark, EchoEye and ColorMark technologies as they apply to any and all systems and products which are designed and/or manufactured for electrophysiology applications to include but not limited to mapping, ablation and internal cardioversion.  The Field of Use specifically excludes permanent pacemaker leads and permanent defibrillator leads attached to permanent implantable pulse generators.

IPSCIO Record ID: 163887

License Grant
Assignor sells, assigns, conveys, transfers and delivers to Assignee, its successors and permitted assigns, the Spot Catheter Patents and the Spot Catheter Technology and the Linear Catheter Patents and the Linear Catheter Technology to be used only in the Field of Use.
License Property
Assignor is in the business of developing implantable cardiac defibrillators and electrophysiology catheters. The IP includes patents and U.S. Patent Applications, Serial Nos. 08/496,947 and 09/073,651 and corresponding foreign patents.
Field of Use
The Field of Use shall mean the radio frequency (RF) cardiac ablation therapy field.  This agreement pertains to the medical industry.

IPSCIO Record ID: 203978

License Grant
The Canadian Licensor grants to Licensee an exclusive, worldwide license, with the right to grant and authorize sublicenses, to Licensors entire interest in and to the Licensed Patents within the Field to make, have made, use, import, have imported, sell, offer for sale and otherwise exploit and distribute Licensed Products within the Field, and practice any method, process or procedure included within the Licensed Patents in the Field.
License Property
The licensed patents are for Two-Dimensional and Three-Dimensional Digital Ultrasound Tracking Systems for surgery.  The Licensed Product means a product within the scope of one or more Valid Claims of the Licensed Patents in the country of manufacture or sale;  produced, processed or otherwise manufactured by a process or method within the scope of one or more Valid Claims of the Licensed Patents in the country of such manufacture; or; used in a process and/or method within the scope of one or more Valid Claims of the Licensed Patents in the country where such product is made or sold.
Field of Use
The Field shall mean use of any medical device and procedure applications in and on the heart that utilize essentially real-time triangulation algorithms to determine the three-dimensional position of transducers, excluding procedures solely and directly related to heart valve surgery.

IPSCIO Record ID: 28166

License Grant
Licensor grants an exclusive worldwide license to the Licensed Technology to manufacture, make, have made, promote, market, use, distribute, sell and have sold Products incorporating or utilizing, and to otherwise commercialize and exploit the Licensed Technology.
License Property
Licensor is the owner of technology and patents relating to enhancing the visualization of biopsy needles or other metallic devices being guided by ultrasound.

The Licensed Technology means the ColorMark(R) technology, and shall include all Licensor's U.S. and foreign patents and patent applications, currently existing or existing in the future, related thereto.

Field of Use
Licensee is involved in the development and distribution of medical equipment.

IPSCIO Record ID: 289542

License Grant
If, and only if, Licensor exercises its option for a license under the CIC Patents pursuant to this agreement, Licensor shall grant (and will cause its Affiliates to grant) to Licensee and its Affiliates the right and option until the expiration of thirty (30) months from the Effective Date or ninety (90) days from the date Licensor exercises its option, whichever is later in time, to obtain a non-exclusive, worldwide, non-transferable, royalty-bearing license under the Savacor Patents.
License Property
Savacor Patents shall mean those patents and patent applications, and all patents and patent applications claiming priority therefrom, that Licensor or its Affiliates acquired from Savacor, Ind. as set forth.  The Savacor Patents shall include the sublicensable patents and patent applications of Cedars Sinai Medical Center listed.

6,970,742 – Method for detecting, diagnosing, and treating cardiovascular disease
6,328,699 – Permanently implantable system and method for detecting, diagnosing and treating congestive heart failure

Field of Use
“CRM Products” means devices for monitoring or electrically stimulating or shocking the heart which are suitable for chronic implantation, in whole or in part, by or with human patients. The term “CRM Products” includes, without limitation: cardiac pacemakers, antitachycardia pacemakers, cardiac resynchronization therapy systems, cardioverters, and defibrillators, including combinations thereof; loop recording systems, implantable cardiac monitoring systems, implantable hemodynamic monitoring systems, pulse generators and other waveform generators for such devices; cardiac lead implant catheters and associated tools; leads, electrodes, sensors, capacitors, batteries, power sources, and all other components for such devices; mechanisms for coupling such generators in a stimulating, shocking, sensing, or monitoring relationship to the heart; and data dispensing, processing, and gathering systems for such devices, including programmers, pacing system analyzers, defibrillation system analyzers, testers, encoders, decoders, transtelephonic and other remote monitoring systems and services for use with implantable devices, transmitters, receivers, and computer software-controlled systems, and including the software. The term “CRM Products” excludes, by way of example and not limitation, nerve stimulators (unless used for cardiac therapy), bone growth stimulators, drug release pumps, cardiac pumps, artificial hearts, prosthetic heart valves, catheter ablation devices, imaging systems, catheter location systems, apparatus for revascularization or correction of other physical defects in heart tissue, arrhythmia mapping devices (except as part of an implantable cardiac therapy or monitoring device), angioplasty devices and EKG monitors (other than cardiac stimulation device programmers or other telemetry devices for use with implantable pulse generators or cardiac monitors) which are standalone, non-ambulatory and not intended for transtelephonic or other remote monitoring.

IPSCIO Record ID: 283410

License Grant
The Foundation grants to Company the following: (a) an exclusive license with the right to sublicense, within the Field and Territory, under the Patent Rights to make, have made, use, offer for sale, sell, and import Licensed Products; and (b) a nonexclusive license, with the right to sublicense, within the Field and Territory, to use the Know-How to develop, make, have made, use, offer for sale, sell, and import Licensed Products.
License Property
Patent Rights shall mean U.S. patent number 8,538,501, and any re-examinations and re-issues thereof, as well as extensions and supplementary protection certificates and any foreign counterpart of any of the foregoing.

8,538,501 – Mapping and ablation catheter system

Licensed Product shall mean any product, process, or service which: (a) the manufacture, use, sale, offer for sale or importation of which infringes an issued claim of the Patent Rights, or that would infringe but for the exception in 35 U.S.C. §271(e)(1), or similar exception in the United States or other countries; or (b) the development, manufacture, use, sale, offer for sale or importation of which incorporates, uses, was derived from, identified by, validated, or developed in whole or in part using the Know-How.

Field of Use
Field shall mean a mapping and ablation catheter system.
Pure EP is a computerized system designed to acquire, digitize, measure, display and store electrocardiographic and intracardiac signals for patients undergoing electrophysiology procedures.
The product sets out to assist electrophysiologists with decision-making during EP procedures in patients with abnormal heart rates and rhythms.
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.